Commercializing Gene Therapies
Using High-Touch Services to Enhance Patient Outcomes
Exosomes from Cancer Cells Could Predict Immunotherapy Responses
Immune-Evasion Mechanism May Help Explain the Differences in Responses to Immunotherapy
Gene Therapy for Rare Diseases
Are We There Yet?
Bioreactors Pull Out Some of the Stops
Balancing Bioreactor and Process Parameters Avoids Production Discord and Amplifies Flows
For full access to this article login to GEN Select now.
Online Exclusive: TempoCal, TempoMito, and TempoVol—Three Biosensors for Research and Drug Discovery
- Over the past decade, genetically encoded biosensors have proved to be powerful reporters of cellular activities, as shown using a variety of model organisms. They are highly amenable to customized designs to suit experimental needs, as they vary in fluorescence range, kinetics, and cellular compartmental targeting. They can be ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.